Clinical Trial: Clinical Trial to Evaluate the Use of Platelet Rich Plasma in Front Hyaluronic Acid in Coxarthrosis
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Clinical Trial Randomized, Double-blind Controlled, Phase III, to Evaluate the Use of Platelet Rich Plasma in Front Hyaluronic Acid in Coxarthrosis
Brief Summary: To evaluate the efficacy and safety of platelet rich plasma (PRP) in patients with coxarthrosis who don´t respond to treatment with NSAIDs, compared to treatment with hyaluronic acid (Hylan G-F 20).
Detailed Summary:
Sponsor: Fundación Pública Andaluza Progreso y Salud
Current Primary Outcome:
- EVA scale for pain measure. [ Time Frame: Through study completion, an average of 1 year. ]The patient assesses the sensation of pain following a horizontal visual analog scale (EVA) with values between 0 ("no pain") and the value 100 ("excruciating pain"). The records taken are recorded in the medical record of the patient.
- Harris Hip Score for pain, function and range of motion measure. [ Time Frame: Through study completion, an average of 1 year. ]It is a questionnaire developed to evaluate hip surgery or replacement. It is widely used for evaluation of hip disorders and treatment methods.
- WOMAC questionnaire for pain, stiffness and joint mobility measure. [ Time Frame: Through study completion, an average of 1 year. ]It is a standardized questionnaire, widely used for assessment of both knee and hip osteoarthritis. It consists of five items for assessing pain (range 0-20), two items that assess the stiffness (range 0-8) and 17 items that evaluate the functionality of the joint (range 0-68).
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud
Dates:
Date Received: February 9, 2016
Date Started: March 2016
Date Completion: December 2017
Last Updated: April 27, 2016
Last Verified: February 2016
